Opioid Treatment Surge Act
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Opioid Treatment Surge Act
This bill requires the Department of Health and Human Services to assess market-share-based fees, for the next 10 years, on drug manufacturers that have produced opioid drugs since 1999. Opioid drugs manufactured to treat opioid addiction, cancer patients, or hospice patients are, however, exempt from this assessment. All assessed fees must be used for the substance abuse prevention and treatment block grant program.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 1662: Opioid Treatment Surge Act. 116th Congress. Open America. https://openamerica.io/bill/116-S-1662/
"S. 1662: Opioid Treatment Surge Act." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-S-1662/.
S. 1662, 116th Cong. (2026), https://openamerica.io/bill/116-S-1662/.
[S. 1662: Opioid Treatment Surge Act](https://openamerica.io/bill/116-S-1662/)